Scholars@Duke
Journal cover image

Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States.

Publication ,  Journal Article
Burns, TM; Sanders, DB; Kaminski, HJ; Wolfe, GI; Narayanaswami, P; Venitz, J
Published in: Muscle Nerve
May 2015
Published version (DOI) Link to item

Duke Scholars

Donald Benjamin Sanders
Author Donald Benjamin Sanders Neurology, Neuromuscular Disease
Altmetric Attention Stats
Dimensions Citation Stats

Published In

Muscle Nerve

DOI

10.1002/mus.24608

EISSN

1097-4598

Publication Date

May 2015

Volume

51

Issue

5

Start / End Page

635 / 637

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Off-Label Use
  • Neurology & Neurosurgery
  • Mycophenolic Acid
  • Myasthenia Gravis
  • Insurance Coverage
  • Immunosuppressive Agents
  • Humans
  • 32 Biomedical and clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Burns, T. M., Sanders, D. B., Kaminski, H. J., Wolfe, G. I., Narayanaswami, P., & Venitz, J. (2015). Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States. Muscle Nerve, 51(5), 635–637. https://doi.org/10.1002/mus.24608
Burns, Ted M., Donald B. Sanders, Henry J. Kaminski, Gil I. Wolfe, Pushpa Narayanaswami, and Jurgen Venitz. “Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States.” Muscle Nerve 51, no. 5 (May 2015): 635–37. https://doi.org/10.1002/mus.24608.
Burns TM, Sanders DB, Kaminski HJ, Wolfe GI, Narayanaswami P, Venitz J. Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States. Muscle Nerve. 2015 May;51(5):635–7.
Burns, Ted M., et al. “Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States.” Muscle Nerve, vol. 51, no. 5, May 2015, pp. 635–37. Pubmed, doi:10.1002/mus.24608.
Burns TM, Sanders DB, Kaminski HJ, Wolfe GI, Narayanaswami P, Venitz J. Two steps forward, one step back: mycophenolate mofetil treatment for myasthenia gravis in the United States. Muscle Nerve. 2015 May;51(5):635–637.
Journal cover image

Published In

Muscle Nerve

DOI

10.1002/mus.24608

EISSN

1097-4598

Publication Date

May 2015

Volume

51

Issue

5

Start / End Page

635 / 637

Location

United States

Related Subject Headings

  • United States
  • Treatment Outcome
  • Off-Label Use
  • Neurology & Neurosurgery
  • Mycophenolic Acid
  • Myasthenia Gravis
  • Insurance Coverage
  • Immunosuppressive Agents
  • Humans
  • 32 Biomedical and clinical sciences